Literature DB >> 18564106

The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats.

Nancy E Badia-Elder1, Angela N Henderson, Megan L Bertholomey, Neil C Dodge, Robert B Stewart.   

Abstract

BACKGROUND: Neuropeptide S (NPS) is a 20-amino-acid peptide, identified in the brain and periphery, that is reported to regulate arousal, anxiety, and feeding behavior. Studies were conducted to determine whether this peptide would alter ethanol intake, sucrose intake, anxiety, and general motor activity in alcohol-preferring (P) and -nonpreferring (NP) rats.
METHODS: Experiment 1: P and NP rats were given 8 weeks of continuous access to ethanol (15% w/v) and water. All rats were implanted with a cannula aimed at either the left or right lateral ventricle and 1 week later were infused with NPS (0.075, 0.3, 1.2 nmol) or artificial cerebrospinal fluid (aCSF) and tested for ethanol, food, and water intake. Experiment 2: The same doses of NPS were administered to a group of P rats and intake of 2.5% (w/v) sucrose was measured. Experiment 3: Infusions of NPS (1.2 nmol) or aCSF were administered to P rats prior to a 5-minute test on an elevated plus maze. Experiment 4: Ethanol naive P and NP rats were infused with NPS (0.075, 0.15, 0.3, 0.6, and 1.2 nmol) or aCSF prior to a 20-minute test in activity monitors.
RESULTS: NPS reduced ethanol intake in P, but not in NP rats. It did not influence sucrose solution intake in P rats. However, an increase in food intake was seen in both rat lines following lower doses of the peptide. NPS did neither alter anxiety-like behavior in the elevated plus maze test nor was there an effect on general motor activity; however, there was an increase in the amount of time spent in the center of the activity monitors following infusions of 0.6 nmol of NPS in P, but not in NP rats, indicating anxioltyic actions of the peptide.
CONCLUSIONS: These data suggest a role for NPS in the modulation of ethanol drinking and possibly anxiety-like behavior in rats selectively bred for high alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564106     DOI: 10.1111/j.1530-0277.2008.00713.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  17 in total

1.  Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.

Authors:  Stewart D Clark; Terrence P Kenakin; Steven Gertz; Carla Hassler; Elaine A Gay; Tiffany L Langston; Rainer K Reinscheid; Scott P Runyon
Journal:  Neuropharmacology       Date:  2017-03-03       Impact factor: 5.250

2.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

3.  Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects.

Authors:  Johan Enquist; Madeline Ferwerda; Anuradha Madhavan; Derek Hok; Jennifer L Whistler
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

4.  Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation.

Authors:  Carla Hassler; Yanan Zhang; Brian Gilmour; Tyler Graf; Timothy Fennell; Rodney Snyder; Jeffrey R Deschamps; Rainer K Reinscheid; Celia Garau; Scott P Runyon
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

Review 5.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

6.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Authors:  Nazzareno Cannella; Marsida Kallupi; Hong Wu Li; Serena Stopponi; Carlo Cifani; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

Review 7.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 8.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.

Authors:  L Raiteri; E Luccini; C Romei; S Salvadori; G Calò
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

10.  Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Caló; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.